CN104822843B - 使用人干细胞样细胞和代谢组学比率预测药物的人发育毒性 - Google Patents

使用人干细胞样细胞和代谢组学比率预测药物的人发育毒性 Download PDF

Info

Publication number
CN104822843B
CN104822843B CN201380057328.0A CN201380057328A CN104822843B CN 104822843 B CN104822843 B CN 104822843B CN 201380057328 A CN201380057328 A CN 201380057328A CN 104822843 B CN104822843 B CN 104822843B
Authority
CN
China
Prior art keywords
test compound
teratogenicity
ratio
cells
fold change
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380057328.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN104822843A (zh
Inventor
A.史密斯
P.韦斯特
J.帕尔默
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shi Te Meter Na Biomarker Research And Development Co
Original Assignee
Shi Te Meter Na Biomarker Research And Development Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shi Te Meter Na Biomarker Research And Development Co filed Critical Shi Te Meter Na Biomarker Research And Development Co
Publication of CN104822843A publication Critical patent/CN104822843A/zh
Application granted granted Critical
Publication of CN104822843B publication Critical patent/CN104822843B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G01N33/6815—Assays for specific amino acids containing sulfur, e.g. cysteine, cystine, methionine, homocysteine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/22—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by measuring secondary emission from the material
    • G01N23/225—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by measuring secondary emission from the material using electron or ion
    • G01N23/2255—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by measuring secondary emission from the material using electron or ion using incident ion beams, e.g. proton beams
    • G01N23/2258—Measuring secondary ion emission, e.g. secondary ion mass spectrometry [SIMS]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201380057328.0A 2012-11-02 2013-11-01 使用人干细胞样细胞和代谢组学比率预测药物的人发育毒性 Active CN104822843B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261721746P 2012-11-02 2012-11-02
US61/721746 2012-11-02
US201361827407P 2013-05-24 2013-05-24
US61/827407 2013-05-24
PCT/US2013/067980 WO2014071137A1 (en) 2012-11-02 2013-11-01 Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomic ratios

Publications (2)

Publication Number Publication Date
CN104822843A CN104822843A (zh) 2015-08-05
CN104822843B true CN104822843B (zh) 2020-01-21

Family

ID=50628081

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380057328.0A Active CN104822843B (zh) 2012-11-02 2013-11-01 使用人干细胞样细胞和代谢组学比率预测药物的人发育毒性

Country Status (9)

Country Link
US (3) US20150301025A1 (enExample)
EP (1) EP2914748B1 (enExample)
JP (2) JP6339581B2 (enExample)
CN (1) CN104822843B (enExample)
CA (1) CA2888064C (enExample)
DK (1) DK2914748T3 (enExample)
HU (1) HUE043604T2 (enExample)
MX (1) MX362991B (enExample)
WO (1) WO2014071137A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016000293A (es) * 2013-07-09 2016-06-21 Stemina Biomarker Discovery Inc Biomarcadores del trastrono del espectro autista.
FI126398B (en) 2014-12-18 2016-11-15 Upm Kymmene Corp Method for chemical testing
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
CN109207551B (zh) * 2017-07-07 2023-05-26 上海睿智化学研究有限公司 一种筛选叶酸代谢相关药物的方法
US20210072230A1 (en) * 2018-03-09 2021-03-11 Stemina Biomarker Discovery, Inc. In vitro assay to predict cardiotoxicity
CN116547722A (zh) * 2020-11-30 2023-08-04 赛诺菲 剂量-反应图的图像分类
CN119667130B (zh) * 2025-02-13 2025-05-09 生态环境部华南环境科学研究所(生态环境部生态环境应急研究所) 一种基于血清组氨酸/犬尿氨酸快速评估双酚类物质暴露毒性效应的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
BRPI0611439A2 (pt) * 2005-05-13 2010-09-08 Lexicon Pharmaceuticals Inc compostos multicìclicos e métodos para uso dos mesmos
MX2008013002A (es) * 2006-04-10 2008-10-17 Wisconsin Alumni Res Found Reactivos y metodos para usar celulas madre embrionarias humanas para evaluar toxicidad de compuestos farmaceuticos y otros quimicos.
AU2011232577C1 (en) * 2010-03-22 2016-07-14 Stemina Biomarker Discovery, Inc. Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics
WO2011143609A1 (en) * 2010-05-14 2011-11-17 Deseret Biologicals, Inc. Formulations of diluted genetic material and methods for making same
US9447506B2 (en) 2012-07-30 2016-09-20 David Whitmore Cathodic protection of a concrete structure

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Identifying developmental toxicity pathway for a subset of ToxCast chemical using human embryonic stem cells and metabolomics;N.C. Kleinstreuer,et al.;《Toxicology and Applied Pharmacology》;20111231;第257卷;112页左栏第3段 *

Also Published As

Publication number Publication date
CA2888064A1 (en) 2014-05-08
EP2914748A4 (en) 2016-06-01
MX2015005476A (es) 2015-10-29
JP2016501516A (ja) 2016-01-21
DK2914748T3 (da) 2019-06-11
CA2888064C (en) 2023-05-30
US20150301025A1 (en) 2015-10-22
JP6339581B2 (ja) 2018-06-06
US10209240B2 (en) 2019-02-19
JP6581244B2 (ja) 2019-09-25
WO2014071137A1 (en) 2014-05-08
EP2914748A1 (en) 2015-09-09
US20190128872A1 (en) 2019-05-02
HUE043604T2 (hu) 2019-08-28
JP2018157823A (ja) 2018-10-11
EP2914748B1 (en) 2019-03-13
US20180128814A1 (en) 2018-05-10
CN104822843A (zh) 2015-08-05
MX362991B (es) 2019-03-01

Similar Documents

Publication Publication Date Title
US10209240B2 (en) Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomic ratios
JP6254561B2 (ja) ヒト幹細胞様細胞及びメタボロミクスを使用した医薬のヒト発生毒性の予測
Collins et al. High throughput toxicity screening and intracellular detection of nanomaterials
Krug et al. Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP+
Lei et al. Colorimetric sensor array for thiols discrimination based on urease–metal ion pairs
Dybas et al. Integrative proteomics reveals an increase in non-degradative ubiquitylation in activated CD4+ T cells
Lanz et al. Genome dilution by cell growth drives starvation-like proteome remodeling in mammalian and yeast cells
Kurdi et al. Amino Acid Profiling of Follicular Fluid in Assisted Reproduction Reveals Important Roles of Several Amino Acids in Patients with Insulin Resistance
US20250264459A1 (en) In vitro assay to predict cardiotoxicity
WO2021072351A1 (en) Diagnosis and treatment of autism spectrum disorders using altered ratios of metabolite concentrations
Carey et al. Influential parameters for the analysis of intracellular parasite metabolomics
Back et al. Site-specific K63 ubiquitinomics reveals post-initiation regulation of ribosomes under oxidative stress
Kumar Investigation of Neuronal Manganese Regulation in Physiology and Disease Using High Throughput Screening, Induced Pluripotent Stem Cells, and Chemical Biology Approaches.

Legal Events

Date Code Title Description
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant